Navigation Links
Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
Date:11/19/2008

However, Generic Erosion and a Dearth of Promising Emerging Therapies Will Result in Modest Annual Growth, According to a New Report from Decision Resources

WALTHAM, Mass., Nov. 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to their improvements in safety and efficacy, physicians are increasingly prescribing next-generation antifungals such as Pfizer's Vfend, Schering-Plough's Noxafil, Merck's Cancidas, Astellas' Mycamine and Pfizer's Eraxis. Following the recent launches of several next-generation azoles (such as Vfend and Noxafil) and echinocandins (such as Cancidas, Mycamine and Eraxis), the severe fungal infections market has become increasingly competitive.

The new Pharmacor report entitled Severe Fungal Infections finds that market competition will continue to intensify and the generic erosion of key agents and a dearth of promising emerging therapies will limit growth to a modest two percent annually from 2007 to 2017 in the severe fungal infections drug market. The report also finds that no new products other than Basilea's isavuconazole are expected to generate significant sales in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan through 2017.

"Interviewed physicians regard isavuconazole as a highly promising new antifungal, and we forecast the agent to be an important driver in the severe fungal infection market through 2017," said Jose Avalos, Ph.D., analyst at Decision Resources. "Isavuconazole provides a favorable spectrum of activity and safety and is likely to be available as both an oral and intravenous therapy. This agent will compete with other marketed drugs in its class and its sales will help offset the declines due to patent expiries of key brands over the next 10 years."

About Severe Fungal Infections'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016
2. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
3. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
4. Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008.
5. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
6. Researchers find roadmap to next-generation cancer therapies
7. Fourth Annual Games for Health Conference Joins Health and Gaming Innovators to Discuss Next-Generation Game Technologies and Health Issues
8. VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System
9. iCAD Introduces Next-Generation TotalLook Film Digitizer
10. Sanofi Pasteur Enters Agreement With Crucell for Next-Generation Biologicals Against Rabies
11. Boston Scientific Announces CE Mark Approval for Next-Generation Cardiac Resynchronization Therapy Defibrillator

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...on could boost self-esteem, researchers say , ...c children are more likely to have handwriting pro...se without autism, researchers say. , The new s...he study participants had autism spectrum disorder... range for perceptual reasoning on an IQ test. ,...
(Date:11/9/2009)...regained sexual function, study says, , ...s were able to restore sexual function to rabbits ...in the lab and implanting it, a new study reports....searchers say the technique could one day be used ..."We were able to show the tissue was able to integ...
(Date:11/9/2009)...Newswire-FirstCall/ - Hard To Treat Diseases (HTDS...ovartis, a US$41 billion international healthcare ...accine partner, Zhejiang Tianyuan Bio-Pharmaceutic...zerland will begin a five-year, $1 billion China i...ally increase its investment in its China R&D ...
(Date:11/9/2009)...w may be too late when it comes to preventing or i...lub, Inc. (Take Off Pounds Sensibly), the nonprofi... (Vocus) November 9, 2009 -- Tomorrow ...roving a diabetes condition, according to TOPS Clu...weight-loss support organization., , ,Diabetes is ...
(Date:11/9/2009)...dy highlights positive influence of sports partici...osemont, IL (Vocus) November 9, 2009 -- As people ...Recent research has highlighted the importance of ...hese issues. However, a new study published in the...idisciplinary Approach reveals that there may be ...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
...patients informed about being paid to enrol them i... phase 4 clinical trials - are a signicnificant pa...s a new drug// and the family doctor reporting any...ortant way of revealing uncommon side effects. ...
...researchers have found that bone loss can be treme...t for kidney stones has the spin-off of increasing... a treatment// for kidney stones. Hence it has bee... a period ranging from 10 to 110 months to prevent...
...are protective substances, produced by the body in...ill the TB bacteria, researchers in the UK report....urnal Nature Medicine,// these heat-shock proteins...aham R. Stewart, of Imperial College of Science Te...
...merican women who are health have increased risk o...research on risk factors for heart disease and str...ia University report on how cholesterol and other ...5 years. The women were followed up for several ye...
... recent study shows that a leaky heart valve raise...brillation (AF) the upper chambers of the heart be...inked to heart attack and stroke.// Researchers at...flows backwards into the upper chamber in people w...
...ew bandages developed by US researchers take an ac...ice show that hydrogel bandages speed up healing.T...and six times and become pliable when wet.// Unlik... The researchers believe that the bandages will...
Other Medicine News:
(Date:11/9/2009)...9 Milestone Scientific I...der in computer-controlled injection technologies,...tented, award-winning STA Single Tooth Anesthesia...5th year of TBSE titled "The Love Dentistry Fest 2.... ,, The STA System is a computer-controlle...
(Date:11/9/2009)... Access MediQuip, LLC, the nation,...able medical device management solutions to the he...cating its corporate headquarters to Lake Mary, Fl... rapid growth, includes a major expansion of the P... in January 2010 and relocation and expansion of t...
(Date:11/9/2009)...re-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasda...m the Company,s Bepreve(TM) (bepotastine besilate .... These results were presented in poster sessions...e of Allergy, Asthma & Immunology (ACAAI) in M...tled, "Treatment of Ocular Itching with Bepotastin...
Breaking Medicine Technology:Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 1Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 2Dysport Added as a Procedure on AmericanHealthandBeauty com 3A Let the Wrinkle Wars Begin 49447 3Special Olympics Minnesotas 2009 Summer Games Continue 49443 1Special Olympics Minnesotas 2009 Summer Games Continue 49443 2Special Olympics Minnesotas 2009 Summer Games Continue 49443 3China Animal Welfare Law Under Review While 36 000 Dogs Culled 4615 1China Animal Welfare Law Under Review While 36 000 Dogs Culled 4615 2
...S, the Netherlands, June 11, 2007-Sugammadex - the...ng developed by Organon,the human healthcare busi...III pivotal trial a 9-12 times faster reversal of,... without evidence,of post operative residual curar...on.1, 2 The results of this pivotal Aurora trial,w...
...ASHINGTON, DC, June 11, 2007 /PRNewswire-FirstCall...d Medicine at Georgetown,University Medical Center...of Neurochem Inc.,s North American Phase III clini...sent today an update on,Neurochem,s investigationa...,s disease (AD). The presentation by Dr. Aisen wil...
Other Medicine Technology:Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 2At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 3At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed) 4
Agarose,separation < 500 bp
...on of agar. Forms gel with superior mechanical qua...on microscope slides or transparent plastic. When ...le or no deterioration on staining with either pro...lling temperature: 42°C. Soluble in Hot H 2 O....
...s and instruments designed to perform the main tes... blood transfusion centers. The system is based ad... or the analysis of digitized images. The quality ...bulin reagents used gives the system an excellent ...
...0 Automated Microplate System, the PK CMV-PA Syste...for the detection of cytomegalovirus. Relative sen...red to EIA measures 99.8% and 99.3% respectively. ...des excellent lot-to-lot consistency and eliminate...
Medicine Products: